Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation

被引：2
|
作者：
Nedeltchev, Krassen [1 ,2 ]
机构：
[1] Triemli Hosp, Dept Neurol, CH-8063 Zurich, Switzerland
[2] Univ Bern, Bern, Switzerland
来源：
STROKE | 2012年 / 43卷 / 03期
关键词：
anticoagulation; apixaban; atrial fibrillation; DABIGATRAN;
D O I：
10.1161/STROKEAHA.111.640961
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [1] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11): : 981 - 992
  • [2] Apixaban versus Warfarin in Atrial Fibrillation
    Simini, Bruno
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 88 - 89
  • [3] Apixaban versus warfarin in patients with atrial fibrillation: examination of ARISTOTLE
    Szczerba, Ewa
    KARDIOLOGIA POLSKA, 2012, 70 (02) : 196 - 200
  • [4] Apixaban versus Warfarin in Atrial Fibrillation REPLY
    Granger, Christopher B.
    Hanna, Michael
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 89 - 89
  • [5] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
    Stanifer, John W.
    Pokorney, Sean D.
    Chertow, Glenn M.
    Hohnloser, Stefan H.
    Wojdyla, Daniel M.
    Garonzik, Samira
    Byon, Wonkyung
    Hijazi, Ziad
    Lopes, Renato D.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    CIRCULATION, 2020, 141 (17) : 1384 - 1392
  • [6] Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
    Bahit, M. Cecilia
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Held, Claes
    Hanna, Michael
    Vinereanu, Dragos
    Hylek, Elaine M.
    Verheugt, Freek
    Goto, Shinya
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    HEART, 2017, 103 (08) : 623 - 628
  • [7] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [8] History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Al-Khatib, Sana M.
    Bahit, M. Cecilia
    Goto, Shinya
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose
    Renda, Giulia
    Horowitz, John
    Granger, Christopher B.
    Wallentin, Lars
    AMERICAN HEART JOURNAL, 2016, 175 : 175 - 183
  • [9] History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Bahit, M. Cecilia
    Commerford, Patrick J.
    Goto, Shinya
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan H.
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose L.
    Wallentin, Lars
    CIRCULATION, 2014, 130
  • [10] Atrial Fibrillation: Apixaban is superior to Warfarin
    Weiss, Johannes
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (02) : 66 - 66
12345